Autor/in Baerlocher, G M 2 Hossfeld, D K 2 Lauseker, M Fabarius, A 1 Gratwohl, A 1 Hanfstein, B 1 Hehlmann, R 1 Heim, D 1 Kolb, H J 1 Kolb, H-J 1 Kraus, M-P 1 Krause, S 1 Krause, S W 1 Miranda, M B 1 Nerl, C 1 Neubauer, A 1 Pfirrmann, M 1 Proetel, U 1 Saußele, S 1 alle zeigenListe einklappen
Assessment of imatinib as first-line treatment of chronic myeloid leukemia:10-year survival results of the randomized CML study IV and impact of non-CML determinants Hehlmann, R Lauseker, M Saußele, S Pfirrmann, M Krause, S Kolb, H J Neubauer, A 2017 - Forschungsinformationssystem des UKE
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV Miranda, M B Lauseker, M Kraus, M-P Proetel, U Hanfstein, B Fabarius, A Baerlocher, G M 2016 - Forschungsinformationssystem des UKE
